The WACC of BioMark Diagnostics Inc (BUX.CN) is 5.8%.
| Range | Selected | |
| Cost of equity | 4.50% - 7.10% | 5.80% |
| Tax rate | 25.90% - 26.50% | 26.20% |
| Cost of debt | 7.00% - 10.30% | 8.65% |
| WACC | 4.5% - 7.1% | 5.8% |
| Category | Low | High |
| Long-term bond rate | 3.2% | 3.7% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.07 | 0.32 |
| Additional risk adjustments | 1.0% | 1.5% |
| Cost of equity | 4.50% | 7.10% |
| Tax rate | 25.90% | 26.50% |
| Debt/Equity ratio | 0.04 | 0.04 |
| Cost of debt | 7.00% | 10.30% |
| After-tax WACC | 4.5% | 7.1% |
| Selected WACC | 5.8% | |